1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Drug Product Listings
Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
| Generic Name | Common Trade Name(s) | Classification |
Date Marketed in Canada (yyyy/mm/dd) |
|---|---|---|---|
| Alpelisib | Piqray | Antineoplastic agent | 2020/03/11 |
| Cabotegravir | Vocabria | Antiretroviral agent | 2020/03/19 |
| Cabotegravir + rilpivirine | Cabenuva | Antiretroviral agent | 2020/03/19 |
| Darolutamide | Nubeqa | Anti-androgen | 2020/03/24 |
| Tafamidis | Vyndaqel | Selective stabilizer of transthyretin - cardiac drug | 2020/04/07 |
| Semaglutide | Rybelsus | Incretin mimetic | 2020/04/19 |
| Warfarin | Coumadin | Anticoagulant | 2020/04/23 |
| Siponimod | Mayzent | Immunomodulatory agent | 2020/04/24 |
| Brolucizumab | Beovu | Antineovascularisation agent | 2020/05/15 |
| Esketamine | Spravato | Antidepressant | 2020/05/20 |
| Infliximab | Avsola | Biological response modifier | 2020/06/01 |
| Sonidegib | Odomzo | Antineoplastic agent | 2020/06/11 |
| Apomorphine | Kynmobi | Nonergot-derivative dopamine receptor agonist | 2020/06/12 |
| Isatuximab | Sarclisa | Antineoplastic agent, monoclonal antibody | 2020/07/03 |
| Sumatriptan + naproxen | Suvexx | Serotonin receptor agonist + NSAID | 2020/07/24 |
| Tibolone | Tibella | Hormone replacement therapy | 2020/07/29 |
| Fremanezumab | Ajovy | Anti-calcitonin gene-related peptide | 2020/08/04 |
| Glasdegib | Daurismo | Antineoplastic agent | 2020/08/10 |
| Daratumumab | Darzalex SC | Antineoplastic agent, monoclonal antibody | 2020/08/12 |
| Etonogestrel | Nexplanon | Hormonal contraceptive | 2020/08/17 |
| Satralizumab | Enspryng | Immunosuppresant | 2020/08/26 |
| Caplacizumab | Cablivi | Antithrombotic agent | 2020/09/04 |
| White birch extract (Betula verrucosa) | Itulatek | Allergy immunotherapy | 2020/09/28 |
| Tucatinib | Tukysa | Antineoplastic agent | 2020/10/08 |
| Voretigene | Luxturna | Cellular and gene therapy | 2020/10/13 |
| Eszopiclone | Lunesta | Hypnotic | 2020/10/20 |
| Teriparatide | Osnuvo | Bone formation agent | 2020/10/27 |
| Indacaterol + glycopyrronium bromide + mometasone | Enerzair Breezhaler | Asthma medication | 2020/11/05 |
| Lemborexant | Dayvigo | Hypnotic | 2020/11/06 |
| Tenapanor | Ibsrela | Sodium/hydrogen exchanger inhibitor | 2020/11/23 |
| Eptinezumab | Vyepti | Prevention of migraine; calcitonin gene-related peptide binding antibody | 2021/01/11 |
| Onasemnogene | Zolgensma | Cellular and gene therapy | 2021/02/04 |
| Ofatumumab | Kesimpta | Immunomudulator | 2021/04/08 |
| Trastuzumab deruxtecan | Enhertu | Antineoplastic agent | 2021/04/15 |
| Ponesimod | Ponvory | Sphingosine 1-phosphate receptor modulator | 2021/04/28 |
| Drospirenone + estetrol | Nextstellis | Oral contraceptive | 2021/06/15 |
